… Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on …

… come to learn about the latest advancements in CAR-T cells and transplant. This course is a major educational … in immunology. I graduated in 2014, around the time when CAR-T cell therapies were making headlines in journals as …

… Tbilisi, Georgia. Arnon Nagler started the session about CAR T-cells for adult ALL. As nowadays the biggest challenge in … category of patients in terms of monoclonal antibodies and CAR-T cells and he underlined the benefits of Autologous … Reports of the 3rd European CAR T-Cell Meeting 4-6 February 2021 - Virtual …

… Tűbingen, Germany, for his study “Standard-of-care CAR-T Cell therapy for large B-Cell Lymphoma: real world data … did you get the idea for it? A: With the increased use of CAR-T cells in daily routine, it is more than natural to ask …

… use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT …

… The role of bridging therapy before CAR-T cell therapy in diffuse large B-cell lymphoma (DLBCL): An …

… to increase our workloads including new treatments such as CAR-T in myeloma and there are many transplant centres in the UK … at the benefits of prehabilitation pre transplant and CAR-T therapy- this has been a collaboration, but a lot of …

… Physicians Sessions Highlight on next generation CAR T-cells and future perspective By Vera Radici, Department of … Transplantation, Udine, Italy. Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major … Reports of the 4th European CAR T-cell Meeting 10-12 February 2022 - Virtual …

… directed immunotherapy (BCDI) on the outcome of CD19 CAR-T cell therapy in aggressive B-cell malignancies, on behalf …

… include cellular therapies considered both high risk e.g. CAR-T cell therapy and low risk e.g mesenchymal stem cells. Donor … standards.  In recent years, the focus has been on CAR-T cells which are principally being applied in the HSCT …